{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:58:24Z","timestamp":1783479504074,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ijantimicag.2012.11.011","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T23:33:48Z","timestamp":1357688028000},"page":"278-280","source":"Crossref","is-referenced-by-count":30,"title":["In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates"],"prefix":"10.1016","volume":"41","author":[{"given":"Emma","family":"Rey-Jurado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griselda","family":"Tud\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Puig","family":"de la Bellacasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateu","family":"Espasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Gonz\u00e1lez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0005","unstructured":"World Health Organization. Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. WHO global report. Geneva, Switzerland: WHO; 2010."},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/09031936.00073611","article-title":"WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","volume":"38","author":"Falzon","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0015","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","article-title":"Fluoroquinolones, tuberculosis, and resistance","volume":"7","author":"Ginsburg","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2012.11.011_bib0020","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1093\/infdis\/jis034","article-title":"New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future","volume":"205","author":"Lienhardt","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2005.05.005","article-title":"Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis","volume":"26","author":"Bhusal","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0924-8579(02)00387-4","article-title":"Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis","volume":"21","author":"Rodriguez-D\u00edaz","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tube.2012.01.005","article-title":"Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis","volume":"92","author":"Rey-Jurado","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0040","unstructured":"National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. Document M24-A. Wayne, PA: NCCLS; 2003."},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/infdis\/140.4.629","article-title":"Comparison of techniques for measurement of in vitro antibiotic synergism","volume":"140","author":"Norden","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1164\/rccm.200901-0078OC","article-title":"Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis","volume":"180","author":"Dorman","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2012.11.011_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0213-005X(11)70018-0","article-title":"New drugs for tuberculosis treatment","volume":"29","author":"S\u00e1nchez","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0041-3879(85)90040-6","article-title":"The action of antituberculosis drugs in short-course chemotherapy","volume":"66","author":"Mitchison","year":"1985","journal-title":"Tubercle"},{"key":"10.1016\/j.ijantimicag.2012.11.011_bib0065","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang","year":"2003","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T12:32:00Z","timestamp":1539952320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912004463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0924857912004463"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.11.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}